← FDA Drug Approvals (Drugs@FDA)

SILDENAFIL CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2019-05-31

Drug application

FDA Application #

ANDA212260

Application type

Abbreviated New Drug Application (Generic)

Brand name

SILDENAFIL CITRATE

Generic name

SILDENAFIL CITRATE

Active ingredients

SILDENAFIL CITRATE

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

NOVITIUM PHARMA

Manufacturer

ANI Pharmaceuticals, Inc.

First approval

2019-05-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown